4574

TAIKO PHARMACEUTICAL CO., LTD.

大幸薬品株式会社
Pharmaceutical
Taiko Pharmaceutical Co.,Ltd. manufactures and sells over-the-counter (OTC) medicines and quasi drugs in Japan and internationally. The company provides OTC medicines under the SEIROGAN, SEIROGAN TOI A and SEIROGAN Quick C, PISHUT OD Tablet brand names; and quasi-drugs under the RAPPA INTESTINAL REGULATOR BF brand names. It offers sanitation control products under the Cleverin PR, Cleverin Pro Stick, and Cleverin Pro name. In addition, the company manufactures and sells wood vinegar-based products. It exports its products. The company was incorporated in 1946 and is headquartered in Osaka, Japan.
← Companies
Price
¥256
Market Cap
¥12.9B
Ent. Value
¥9.4B
Net Cash
¥3.5B
Shares Out.
50.3M
P / E
13.9×
EV / EBIT
20.5×
P / Book
1.51×
P / NCAV
2.75×
Div. Yield
1.29%
Financials
Metric FY 2025
EDINET ↗ 		FY 2024
EDINET ↗ 		FY 2023
EDINET ↗ 		FY 2022
EDINET ↗ 		FY 2021
EDINET ↗
Net Sales ¥6.4B ¥6.3B ¥6.1B ¥5.0B ¥11.3B
Cost of Sales ¥2.9B ¥2.6B ¥3.5B ¥4.0B ¥8.0B
Gross Profit ¥3.5B ¥3.7B ¥2.6B ¥1.1B ¥3.3B
SG&A ¥3.0B ¥3.0B ¥3.6B ¥4.2B ¥7.7B
Operating Income ¥459M ¥629M ¥-1.0B ¥-3.1B ¥-4.9B
Non-Operating Income ¥37M ¥86M ¥82M ¥109M ¥108M
Interest Income ¥16M ¥30M ¥25M ¥5M ¥3M
Non-Operating Expenses ¥14M ¥28M ¥325M ¥383M ¥1.3B
Interest Expense ¥5M ¥8M ¥8M ¥10M ¥6M
Ordinary Income ¥482M ¥688M ¥-1.2B ¥-3.4B ¥-6.1B
Pre-tax Income ¥958M ¥565M ¥-3.6B ¥-4.9B ¥-8.9B
Income Taxes ¥34M ¥-332M ¥47M ¥25M ¥706M
Current Tax ¥38M ¥24M ¥23M ¥6M ¥27M
Deferred Tax ¥-3M ¥-357M ¥24M ¥18M ¥679M
Net Income (owners) ¥923M ¥898M ¥-3.6B ¥-4.9B ¥-9.6B
Comprehensive Income ¥536M ¥1.1B ¥-3.5B ¥-4.8B ¥-9.5B
EBITDA ¥724M ¥885M ¥-301M ¥-2.3B ¥-4.0B
EPS ¥18.38 ¥17.90 ¥-76.25 ¥-112.26 ¥-220.52
Shares Outstanding 50.3M 50.2M 49.9M 43.6M 43.6M
Shares Issued (total) 50.6M 50.6M 50.4M 44.1M 44.1M
Treasury Shares 0.4M 0.4M 0.5M 0.6M 0.6M